Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Viral Vector and Plasmid DNA Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of around 14% during the review period (2022 to 2027).
Viral Vector and Plasmid DNA Market Overview
Molecular biologists frequently use viral vectors to introduce genetic material into cells. In order to efficiently carry their genomes inside the cells they infect through the process of transduction, viruses have evolved specialised molecular processes. The market for producing viral vectors and plasmid DNA is expanding as a result of the rising incidence of target illness and disease as well as the efficiency of viral vectors in delivering gene therapy. This increase is made possible by funding for the development of gene therapy as well as ongoing research into cell and gene therapies based on viral vectors. The demand for scalable production of gene therapy vectors is also anticipated to rise as a result of an increase in the number of gene therapy-based discovery initiatives launched by biotechnology and pharmaceutical businesses.
The prevalence of numerous genetic abnormalities and different illnesses has led to a surge in the need for viral vector and plasmid DNA production. The demand for viral vector and plasmid DNA manufacturing is also driven by factors like technological developments to address problems with conventional vector production methods, an increase in clinical studies, and an increase in gene therapy candidates who are moving quickly through the various stages of clinical development. An increase in financing for R&D activities in gene therapy as well as rising public awareness of gene therapy are driving the market for viral vectors and plasmid DNA synthesis to grow.
The report aspects discussed the profile of the top Manufacturers of the global Viral Vector and Plasmid DNA Market. These aspects include financial Status of major companies, trending advancements and entire market scenario. Growth of the report have examined Viral Vector and Plasmid DNA Market production, demand and growth Potential, geographic analysis, as well as current market developments in Various regions and countries.
Who are the Major Players in Viral Vector and Plasmid DNA Market?
The Viral Vector and Plasmid DNA Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market includes Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector, Lonza, BioReliance, MolMed, FUJIFILM Diosynth Biotechnologies, UniQure, Aldevron, Richter-Helm, Eurogentec, OBiO Technology, Yposkesi, Cell and Gene Therapy Catapult, MassBiologics, Biovian, VGXI, Gene Synthesis, PlasmidFactory, Jikai Gene
Industry News:
Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology
11 March 2022
Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or the “Company"), a leading gene and cell therapy group, is pleased to announce that it has completed its deal with Homology Medicines Inc. (Nasdaq: FIXX) (“Homology”), a genetic medicines company, to establish Oxford Biomedica Solutions LLC, a new US-based full scope, Adeno-Associated Virus (AAV) manufacturing and innovation business.
What are the major Applications, Types and Regions for Viral Vector and Plasmid DNA Market?
Viral Vector and Plasmid DNA Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Applications it is segmented into
- Cancer
- Virus Infection
- Hereditary Disease
Viral Vector and Plasmid DNA Market Regional Analysis
North America accounted for the largest market share and Europe was the second-largest market in 2020. The growth of the viral vector and plasmid DNA manufacturing in the US is mainly due to the large volume of generic drugs under the development stage, creating higher demand for viral vector manufacturing. The increasing importance of the Contract Development And Manufacturing Organization (CDMO) in the viral vector for manufacturing vaccines, drugs, and related treatments.
All these factors greatly affect the Viral Vector and Plasmid DNA Market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
The Viral Vector and Plasmid DNA Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Graphene-enhanced Composites Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Viral Vector and Plasmid DNA Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2028 CAGR
|
CAGR of 14% during the review period (2022 to 2027).
|
By Type
|
|
By Application
|
- Cancer
- Virus Infection
- Hereditary Disease
|
By Companies
|
Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector, Lonza, BioReliance, MolMed, FUJIFILM Diosynth Biotechnologies, UniQure, Aldevron, Richter-Helm, Eurogentec, OBiO Technology, Yposkesi, Cell and Gene Therapy Catapult, MassBiologics, Biovian, VGXI, Gene Synthesis, PlasmidFactory, Jikai Gene
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of pages
|
132
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Viral Vector and Plasmid DNA Market Report
- Evaluate Viral Vector and Plasmid DNA Market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
- Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
- Analyze the sales and distribution channels across geographies to enhance top-line revenues.
- Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Viral Vector and Plasmid DNA Market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
- Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
Frequently Asked Questions
What is the study period of this market?
The Viral Vector and Plasmid DNA Market is studied from 2017 - 2027.
What is the growth rate of Viral Vector and Plasmid DNA Market?
The Viral Vector and Plasmid DNA Market is growing at a CAGR of 14% over the next 5 years.
Who are the key players in Viral Vector and Plasmid DNA Market?
Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector, Lonza, BioReliance, MolMed, FUJIFILM Diosynth Biotechnologies, UniQure, Aldevron, Richter-Helm, Eurogentec, OBiO Technology, Yposkesi, Cell and Gene Therapy Catapult, MassBiologics, Biovian, VGXI, Gene Synthesis, PlasmidFactory, Jikai Gene
What region does this Viral Vector and Plasmid DNA Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Viral Vector and Plasmid DNA Market?
Plasmid DNA, Viral Vector
What are the major end-use applications of Viral Vector and Plasmid DNA Market?
Cancer, Virus Infection, Hereditary Disease
